Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Genome-Wide Association Study Identifies Variation in ABO As Risk Factor for Platelet Reactivity in Heparin-Induced Thrombocytopenia

Jason B Giles, Jérôme Rollin, PhD, Christian M Shaffer, Heidi E Steiner, Yukihide Momozawa, DVM,PhD, Ian Stanaway, PhD, Taisei Mushiroda, Claire Pouplard, PharmD, PhD, Nancy Heddle, MSc, Michiaki Kubo, MDPhD, Elizabeth Phillips, MD, Theodore E. Warkentin, MD, Yves Gruel, MD PhD, Andreas Greinacher, MD, Dan Roden, MD, Jason Karnes, PhDPharmD

Blood (2020) 136 (Supplement 1): 38–39.

https://doi.org/10.1182/blood-2020-139651

Published: 2020

Journal Articles

Rivaroxaban for Treatment of Suspected or Confirmed Heparin-Induced Thrombocytopenia Study

Lori Ann Linkins, MD MSc, FRCPC, Theodore E. Warkentin, MD, Menaka Pai, MD MSc, FRCP(C), Sudeep Shivakumar, MD, Rizwan Manji, MD PhD MBA, Philip S Wells, MD FRCPC, MSc, Cynthia M Wu, MD FRCPC, Ishac Nazi, PhD, Mark A. Crowther, MD MSc, FRCPC

Blood (2015) 126 (23): 3468.

https://doi.org/10.1182/blood.V126.23.3468.3468

Published: 2015

Journal Articles

Difficulties in Establishing the Cause of Thrombocytopenia Among Ambulatory Patients Referred to Hematology: An Agreement Study

Mary Salib, MD, Robert Clayden, Rumi Clare, B.Sc., Grace Wang, MMath, Theodore E. Warkentin, MD, Mark A. Crowther, MD, Wendy Lim, MD MSc., FRCPC, Donald M. Arnold, MD MSc

Blood (2014) 124 (21): 3521.

https://doi.org/10.1182/blood.V124.21.3521.3521

Published: 2014

Journal Articles

Low Level Platelet-Activating Antibodies in Patients Suspected of Having Heparin-Induced Thrombocytopenia but Testing Negative in the ”Gold Standard” Functional Test

Ishac Nazi, PhD, Donald M Arnold, MD, James W Smith, BSc, MT, Theodore E. Warkentin, MD, Jane C Moore, BSc, MT, Peter Horsewood, PhD, John G. Kelton, MD FRCPC

Blood (2014) 124 (21): 2757.

https://doi.org/10.1182/blood.V124.21.2757.2757

Published: 2014

Journal Articles

Combination Of 4T’s Score and Rapid Gel Centrifugation Assay Excludes HIT In a Prospective Cohort Study

Lori Ann Linkins, MD, MSc, FRCPC, Shannon M. Bates, MD, Agnes Y.Y. Lee, MD, MSc, FRCPC, Theodore E. Warkentin, MD

Blood (2013) 122 (21): 3535.

https://doi.org/10.1182/blood.V122.21.3535.3535

Published: 2013

Journal Articles

Spontaneous Heparin-Induced Thrombocytopenia Syndrome: Two New Cases and a Proposal For Defining This Disorder

Theodore E. Warkentin, MD, Paul Andrew Basciano, MD, Richard A. Bernstein, M.D., Ph.D.

Blood (2013) 122 (21): 2328.

https://doi.org/10.1182/blood.V122.21.2328.2328

Published: 2013

Journal Articles

Identifying Drugs Implicated in Drug-Induced Immune Thrombocytopenia Using Levels of Evidence Applied to Laboratory Tests,

Donald M. Arnold, MD, Theodore E. Warkentin, MD, James W. Smith, BSc, Aliya Esmail, Sadiya Kukaswadia, MD, Lori Dewar, John G. Kelton, MD, FRCPC

Blood (2011) 118 (21): 3304.

https://doi.org/10.1182/blood.V118.21.3304.3304

Published: 2011

Journal Articles

Laboratory HIT Testing in Critically Ill Patients

Mark A. Crowther, MD, FRCPC, Stephan Langevin, MD, Jamie L Cooper, MD, Peter Dodek, MD, John Muscedere, MD, Martin Albert, MD, Kosar Khwaja, MD, Jim Kutsiogiannis, MD, Geeta Mehta, MD, James Klinger, MD, Jan Friedrich, MD, Lauralyn McIntyre, MD, Marlies Ostermann, MD, Gordon Guyatt, MD, Nicole Zytaruk, RN, Diane Heels-Ansdell, MSc, Jo-Ann Sheppard, BSc, Deborah J Cook, MD, Theodore E. Warkentin, MD

Blood (2011) 118 (21): 198.

https://doi.org/10.1182/blood.V118.21.198.198

Published: 2011

Journal Articles

4Ts HIT Scoring in the Medical-Surgical ICU

Mark A. Crowther, MD, FRCPC, Diane Heels-Ansdell, MSc, David Williamson, B.Pharm., M.Sc, BCPS, John Granton, MD, Lisa Burry, Francois Lamontagne, MD, Simon Finfer, MD, Ellen McDonald, RN, Shirley Vallance, RN, James Klinger, MD, Jan Friedrich, MD, Bojan Paunovic, MD, Stephen Walter, PhD, Nicole Zytaruk, RN, Deborah J Cook, MD, Theodore E. Warkentin, MD

Blood (2011) 118 (21): 4669.

https://doi.org/10.1182/blood.V118.21.4669.4669

Published: 2011

Journal Articles

Inter-Rater Reliability of the 4Ts Scoring System for Diagnosing Heparin-Induced Thrombocytopenia in Critically Ill Patients.

Mark A. Crowther, MD, Nicole Zytaruk, Katherine Krolicki, Suzanne Duchesne, Theodore E. Warkentin, MD, Diane Heels-Ansdell, Jo-Ann Sheppard, BSc, Stephen Walter, Gordon Guyatt, Cook Deborah

Blood (2009) 114 (22): 3995.

https://doi.org/10.1182/blood.V114.22.3995.3995

Published: 2009

Journal Articles

Incidence of HPA-9b in Testing for Neonatal Alloimmune Thrombocytopenia.

James W. Smith, BSc, Kristen Chamberlain, BSc, Diana Moffatt, MLT, Aurelio Santos, BSMT, Denise Neutel, MLT, Jane Moore, BSc, Theodore E. Warkentin, MD, Donald M. Arnold, MD, John G. Kelton, MD

Blood (2007) 110 (11): 3214.

https://doi.org/10.1182/blood.V110.11.3214.3214

Published: 2007

Journal Articles

Platelet-Activating Anti-Platelet Factor 4/Polyanion Antibodies without Preceding Heparin Therapy: A Transient Autoimmune Disorder Resembling Heparin-Induced Thrombocytopenia (“Spontaneous HIT”).

Theodore E. Warkentin, MD, Richard M. Jay, MD, Michael Makris, MD, John G. Kelton, MD

Blood (2006) 108 (11): 1047.

https://doi.org/10.1182/blood.V108.11.1047.1047

Published: 2006

Journal Articles

An Algorithm for “Indeterminate” Test Results in the Platelet Serotonin Release Assay for Heparin-Induced Thrombocytopenia (HIT).

Carol A. Smith, RT, Andrew E. Warkentin, Theodore E. Warkentin, MD, Donald M. Arnold, MD, Jane C. Moore, BSc, ART, John G. Kelton, MD

Blood (2006) 108 (11): 1048.

https://doi.org/10.1182/blood.V108.11.1048.1048

Published: 2006

Journal Articles

Towards a Conceptual Framework for Diagnosis of Heparin-Induced Thrombocytopenia (HIT).

Gregory K. Lo, MD, Theodore E. Warkentin, MD

Blood (2005) 106 (11): 1234.

https://doi.org/10.1182/blood.V106.11.1234.1234

Published: 2005

Journal Articles

Laboratory Testing for Hit Antibodies: How Much Class Do We Need?.

Theodore E. Warkentin, MD, Jo-Ann I. Sheppard, Jane C. Moore, Kathleen M. Moore, Christopher S. Sigouin, John G. Kelton, MD

Blood (2004) 104 (11): 3022.

https://doi.org/10.1182/blood.V104.11.3022.3022

Published: 2004

Journal Articles

Argatroban Inhibits Human Factor Xa at Therapeutic Drug Levels: An Explanation for Its Prolongation of the INR.

Theodore E. Warkentin, MD, Andreas Greinacher, MD, Sharon Craven, Lori Dewar, Jo-Ann I. Sheppard, Frederick A. Ofosu, PhD

Blood (2004) 104 (11): 1845.

https://doi.org/10.1182/blood.V104.11.1845.1845

Published: 2004

NARROW

Genome-Wide Association Study Identifies Variation in ABO As Risk Factor for Platelet Reactivity in Heparin-Induced Thrombocytopenia

Rivaroxaban for Treatment of Suspected or Confirmed Heparin-Induced Thrombocytopenia Study

Difficulties in Establishing the Cause of Thrombocytopenia Among Ambulatory Patients Referred to Hematology: An Agreement Study

Low Level Platelet-Activating Antibodies in Patients Suspected of Having Heparin-Induced Thrombocytopenia but Testing Negative in the ”Gold Standard” Functional Test

Combination Of 4T’s Score and Rapid Gel Centrifugation Assay Excludes HIT In a Prospective Cohort Study

Spontaneous Heparin-Induced Thrombocytopenia Syndrome: Two New Cases and a Proposal For Defining This Disorder

Identifying Drugs Implicated in Drug-Induced Immune Thrombocytopenia Using Levels of Evidence Applied to Laboratory Tests,

Laboratory HIT Testing in Critically Ill Patients

4Ts HIT Scoring in the Medical-Surgical ICU

Inter-Rater Reliability of the 4Ts Scoring System for Diagnosing Heparin-Induced Thrombocytopenia in Critically Ill Patients.

Incidence of HPA-9b in Testing for Neonatal Alloimmune Thrombocytopenia.

Platelet-Activating Anti-Platelet Factor 4/Polyanion Antibodies without Preceding Heparin Therapy: A Transient Autoimmune Disorder Resembling Heparin-Induced Thrombocytopenia (“Spontaneous HIT”).

An Algorithm for “Indeterminate” Test Results in the Platelet Serotonin Release Assay for Heparin-Induced Thrombocytopenia (HIT).

Towards a Conceptual Framework for Diagnosis of Heparin-Induced Thrombocytopenia (HIT).

Laboratory Testing for Hit Antibodies: How Much Class Do We Need?.

Argatroban Inhibits Human Factor Xa at Therapeutic Drug Levels: An Explanation for Its Prolongation of the INR.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only